Back to Explorer

Unique Device Identifier Requirements for Combination Products: Draft Guidance for Industry

DraftOffice of the Commissioner,Office of Clinical Policy and Programs,Office of Combination Products Center for Biologics Evaluation and Research Center for Drug Evaluation and Research Center for Devices and Radiological Health06/25/2025

Description

This document is intended to assist industry and FDA staff in understanding how FDA’s unique device identifier (UDI) requirements at 21 CFR part 801 subpart B and part 830 subpart E apply to combination products with device constituent parts.  This guidance outlines the requirements, recommendations, and best practices for UDI labeling and for submission of information to the Global Unique Device Identification Database (GUDID) for such combination products. This guidance also provides hypothetical examples to illustrate how UDI requirements can be met for these combination products.

Scope & Applicability

Product Classes

8
Combination Product

Products combining drug, device, or biological constituents; Generally recommended for Enhanced Documentation; Requires 14971-based framework incorporating ICH Q9; A drug-device combination where the device constituent part detects ingestion.

Class I device

Device category that may be exempt from certain UDI requirements if GMP exempt.

Drug-led combination product

Products that properly bear an NDC and are not required to bear a UDI.

Device-led combination product

Products that must bear a UDI and should not bear an NDC.

Single-Entity Combination Product

Physically or chemically combined components like prefilled syringes; Required to bear UDI unless it bears an NDC.; A combination product where components are physically or chemically combined

Co-Packaged Combination Product

Separate products packaged together in a single unit; Compliance options include UDI on the product or NDC plus UDI on device parts.; A combination product where components are packaged together

Cross-Labeled Combination Product

Separately packaged products intended for use only with each other; Constituent parts are separately distributed; device parts require UDI.; A combination product where components are packaged separately but labeled for use together

Device Convenience Kit

Two or more different medical devices packaged together.; Mentioned in recommendations for co-packaged products

Stakeholders

1
Labeler

Person who causes a label to be applied or modified; The entity responsible for submitting information to GUDID.; Entity responsible for identifying device constituent parts

Regulatory Context

Attributes

3
Lot or batch

Production identifier element

Serial number

Production identifier element

Expiration date

should be based on appropriate supportive stability data

Related CFR Sections (10)

Related Warning Letters (10)

  • CGMP/QSR/Medical Devices/Adulterated

    Envoy Medical Inc.

    2025-12-09
  • CGMP/QSR/Medical Devices/Adulterated

    Hong Qiangxing Shenzhen Electronics Limited

    2025-11-25
  • CGMP/QSR/Medical Devices/Adulterated

    Contec Medical Systems Co., Ltd.

    2025-10-28
  • CGMP/QSR/Medical Devices/Adulterated/Misbranded

    Royal Philips

    2025-10-28
  • CGMP/QSR/Medical Devices/Adulterated/Misbranded

    Qianjiang Kingphar Medical Material Co Ltd.

    2025-10-28
  • CGMP/QSR/Medical Devices/Adulterated

    LEVO AG

    2025-10-21
  • CGMP/QSR/Medical Devices/Adulterated

    Technological Medical Advancements LLC

    2025-10-07
  • Medical Device/Adulterated/Misbranded/Lacks PMA and/or 510(k)

    The Richline Group, Inc.

    2025-09-23
  • Investigational Device Exemptions (IDE)/Premarket Approval Application (PMA) Adulterated Device

    SeniorLife Technologies, Inc.

    2025-09-16
  • CGMP/QSR/Medical Devices/Adulterated

    Miach Orthopaedics

    2025-08-26

See Also (8)